up-icon

Kala Azar

Kala Azar, the most severe form of leishmaniasis also known as Visceral leishmaniasis, is a life-threatening disease caused by Leishmania parasites. There are over 600 million people at risk worldwide and 50,000-90,000 new cases of Kala Azar happen per year. 5,710 deaths were reported in 2019. Most of the cases are found in countries like India, Brazil, Kenya, Somalia.

about-icon

About

Kala Azar is transmitted through the bites of infected female phlebotomine sandflies, which feed on blood to produce eggs. People with HIV are at a much higher risk of getting infected. It affects the poorest of the poor, being associated with malnutrition, population displacement, poor housing, a weak immune system, and lack of financial resources. Early diagnosis and effective prompt treatment reduces the prevalence of the disease and prevents disabilities and death. Vector control helps to reduce or interrupt transmission of disease by decreasing the number of sandflies.

icons-02

Diagnosis

Kala Azar is diagnosed by combining observations from a physical exam with parasitological or antibody-based diagnostics. Other approaches for visceral leishmaniasis diagnosis involve antibody detection using the rK39 rapid diagnostic test (RDT) and the alternative Direct Agglutination Test (DAT) to confirm infection.

icons-04

Prognosis

Kala Azar is a treatable and curable disease, which requires an immunocompetent system because medicines will not get rid of the parasite from the body, thus the risk of relapse if immunosuppression occurs. A skin condition known as post-kala-azar dermal leishmaniasis (PKDL) may appear months or years after successful treatment for visceral leishmaniasis.

Kala Azar Test-Kit

CLICK ON THE PRODUCT FOR DETAILS

Kala Azar is crucial for accurate and timely diagnosis,enabling healthcare professionals to make informed decisions quickly. Its reliability and ease of use ensure efficent patient care and improved health outcomes.

Rapid Test Kits

Kala Azar Test

Rapid test for qualitative detection of IgG antibody to Leishmania (Kala Azar) in human serum / plasma

Kala Azar Dipstick Test

Dipstick Test for qualitative detection of IgG antibody of Leishmania (Kala Azar) in human serum / plasma / whole blood